Search Results - Jakob Dupont

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).

    Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). by Étienne Mornet, Jakob Dupont, A Vitek, Perrin C. White

    Published 1989
    Artigo
    Save to List
    Saved in:
  2. 2
    Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)

    Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β) by Étienne Mornet, Jakob Dupont, A Vitek, Perrin C. White

    Published 1989
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors

    GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors by David G. DeNardo, Anna Galkin, Jakob Dupont, Lei Zhou, Johanna C. Bendell

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.

    A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin. by Perrin C. White, Jakob Dupont, M I New, E Leiberman, Ze’ev Hochberg, Ariel Rösler

    Published 1991
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Vascular Endothelial Growth Factor-Trap Overcomes Defects in Dendritic Cell Differentiation but Does Not Improve Antigen-Specific Immune Responses

    Vascular Endothelial Growth Factor-Trap Overcomes Defects in Dendritic Cell Differentiation but Does Not Improve Antigen-Specific Immune Responses by Ingo Fricke, Noweeda Mirza, Jakob Dupont, Craig Lockhart, Autumn L. Jackson, Ji‐Hyun Lee, Jeffrey A. Sosman, Dmitry I. Gabrilovich

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

    Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. by Phyllis Speiser, Jakob Dupont, Dongjian Zhu, Joan Serrat, Mimi Buegeleisen, M T Tusié-Luna, Martin Lesser, Maria I. New, Perrin C. White

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors

    A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors by David C. Smith, Rashmi Chugh, Amita Patnaik, Kyriakos P. Papadopoulos, Min Wang, Ann M. Kapoun, Lu Xu, Jakob Dupont, Robert Stagg, Anthony W. Tolcher

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors

    A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors by David C. Smith, Peter D. Eisenberg, Georgy M. Manikhas, Rashmi Chugh, Matthew A. Gubens, Robert Stagg, Ann M. Kapoun, Lu Xu, Jakob Dupont, Branimir I. Šikić

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma

    Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma by Mario M. Leitão, Robert A. Soslow, Daisuke Nonaka, Adam B. Olshen, Carol Aghajanian, Paul Sabbatini, Jakob Dupont, Martee L. Hensley, Yukio Sonoda, Richard R. Barakat, Sibyl Anderson

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40

    Early Detection and Prognosis of Ovarian Cancer Using Serum YKL-40 by Jakob Dupont, Meena K. Tanwar, Howard T. Thaler, Martin Fleisher, Noah D. Kauff, Martee L. Hensley, Paul Sabbatini, Sibyl Anderson, Carol Aghajanian, Eric C. Holland, David R. Spriggs

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors

    Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors by William P. Tew, Michael S. Gordon, John R. Murren, Jakob Dupont, S. Pezzulli, Carol Aghajanian, Paul Sabbatini, David S. Mendelson, Lawrence Schwartz, Scott Gettinger, Amanda Psyrri, Jesse M. Cedarbaum, David R. Spriggs

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

    Phase II Study of CT-2103 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma by Paul Sabbatini, Carol Aghajanian, Don S. Dizon, Sybil Anderson, Jakob Dupont, John V. Brown, William A. Peters, Andrew Jacobs, Aminder Mehdi, Saul E. Rivkin, Amy J. Eisenfeld, David R. Spriggs

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission

    Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission by Catherine Diefenbach, Sacha Gnjatic, Paul Sabbatini, Carol Aghajanian, Martee L. Hensley, David R. Spriggs, Alexia Iasonos, Helen Lee, Bo Dupont, S. Pezzulli, Achim A. Jungbluth, Lloyd J. Old, Jakob Dupont

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer

    Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer by Stephen A. Cannistra, Ursula A. Matulonis, Richard T. Penson, Julie Hambleton, Jakob Dupont, Howard Mackey, Jeffrey A. Douglas, Robert A. Burger, Deborah K. Armstrong, Robert M. Wenham, William P. McGuire

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Phase I Study of the Novel Epothilone Analog Ixabepilone (BMS-247550) in Patients With Advanced Solid Tumors and Lymphomas

    Phase I Study of the Novel Epothilone Analog Ixabepilone (BMS-247550) in Patients With Advanced Solid Tumors and Lymphomas by Carol Aghajanian, Howard A. Burris, Suzanne F. Jones, David R. Spriggs, Marvin B. Cohen, Ronald Peck, Paul Sabbatini, Martee L. Hensley, F. Anthony Greco, Jakob Dupont, Owen A. O’Connor

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas

    Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas by Xingxing Zang, Peggy Sullivan, Robert A. Soslow, Rebecca Waitz, Victor E. Reuter, Andrew S. Wilton, Howard T. Thaler, Manonmani Arul, Susan F. Slovin, Joyce Wei, David R. Spriggs, Jakob Dupont, James P. Allison

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

    Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors by A. Craig Lockhart, Mace L. Rothenberg, Jakob Dupont, Wendy Cooper, Paul Chevalier, Lars Sternås, Giliane Buzenet, Elizabeth Koehler, Jeffrey A. Sosman, Lawrence H. Schwartz, David H. Gültekin, Jason A. Koutcher, Edwin F. Donnelly, Ric Andal, Isabelle Dancy, David R. Spriggs, William P. Tew

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Activating <i>NOTCH1</i> Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors

    Activating <i>NOTCH1</i> Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potent... by Renata Ferrarotto, Yoshitsugu Mitani, Lixia Diao, Irene Guijarro, Jing Wang, Patrick A. Zweidler‐McKay, Diana Bell, William N. William, Bonnie S. Glisson, Michael J. Wick, Ann M. Kapoun, Amita Patnaik, Gail Eckhardt, Pamela N. Münster, Leonardo Faoro, Jakob Dupont, J. Jack Lee, P. Andrew Futreal, Adel K. El‐Naggar, John V. Heymach

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer

    A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer by Zishuo Ian Hu, Johanna C. Bendell, Andrea J. Bullock, Noelle K. LoConte, Hassan Hatoum, Paul S. Ritch, Hugo Hool, Joseph W. Leach, James F. Sanchez, Davendra Sohal, John H. Strickler, Ravindranath Patel, Andrea Wang‐Gillam, Irfan Firdaus, Kenneth H. Yu, Ann M. Kapoun, Eric Holmgren, Lei Zhou, Jakob Dupont, Vincent J. Picozzi, Vaibhav Sahai, Eileen M. O’Reilly

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: